System Alert

The Project Work Plan (PWP) Management Module (PWPM) is now live. The PWPM enables grantees to collaborate with BPHC to modify project objectives and activities for HCCN, NTAP, and PCA awards throughout the post-award lifecycle.  Be on the lookout for user guides in the Knowledge Base pages.

SYSTEM UPDATE ALERT:

 

Health Center Program Change in Scope (CIS) Requests:

The CIS module will be unavailable from October 20 through November 19, 2026, while HRSA updates the system. The CIS module will reopen November 20, 2026.

 

HRSA will close:

  • New CIS requests not submitted to HRSA by 11:59 p.m. ET on October 19.
  • CIS requests returned for clarifying information (Change Requests) not resubmitted to HRSA by 11:59 p.m. ET on October 24.

You can create and submit a new CIS request when the CIS module reopens November 20.

 

Health Center Program Funding and Look-Alike Designation Applications:

Applications not submitted to HRSA by 5:00 p.m. ET on November 19, 2026, will lose data you entered in scope-related forms (Form 5A: Services Provided, Form 5B: Service Sites, and Form 5C: Other Activities/Locations). Applicants will not need to recomplete their entire application; they will only need to re-enter data in these three scope-related forms (Form 5A, Form 5B, and Form 5C) once the system reopens November 20. This does not impact applications with read-only scope-related forms.
Skip to Main Content

HRSA Electronic Handbooks

Funding Cycle View

Expand

Sickle Cell Disease Treatment Demonstration Program

  • Program Name:Sickle Cell Treatment Demonstration Program
  • Activity Code:U1E
  • Application Available:2/23/2021
  • Application Deadline:5/3/2021
  • Created By:Beach, Dawn
  • Created On:11/7/2019
  • Last Updated by:Wildberger, William
  • Last Updated On:2/23/2021
  • Estimated Project Start Date:9/1/2021
 
Collapse

 Details of the changes posted in this announcement

Not Available
 
Collapse

 Announcement Information

Announcement Number HRSA-21-032
Announcement Code
CFDA Number 93.365
Provisional No
Activity Code U1E
Competitive Yes
Fiscal Year 2021
 
Collapse

 Purpose

This notice announces the opportunity to apply for funding under the Sickle Cell Disease Treatment Demonstration Program (TDP). The purpose of the TDP is to increase access for individuals with sickle cell disease (SCD) to quality, coordinated, comprehensive care by: 1) increasing the number of clinicians or health professionals knowledgeable about the care of SCD, 2) improving the quality of care provided to individuals with SCD, and 3) improving care coordination with other providers.
 
Collapse

 Application Information

Application Available 02/23/2021
Application Deadline 05/03/2021
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 07/02/2021
Letter of Intent Not required
Application Package SF424
Allow Applications to be Reopened in EHBs No
FOA Available Yes
Competitive Application Types Supported New; Continuation & Supplement
Allow Electronic Submission N/A
Page Limit for Application
Attachments 		80
Allow Multiple Applications
from an Organization from Grants.gov 		No
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov
 
Collapse

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 09/01/2021
Estimated Project End Date 08/31/2026
Estimated Amount of this Competition $5,000,000.00
Estimated Number of Awards 5
Estimated Average Size of Awards $0.00
Cost Sharing No
Cooperative Agreement Yes
 
Collapse

 Contact Information

Name Alisha S. Keehn, MPA
Email akeehn@hrsa.gov
Phone Number (301) 945-4817
 
Collapse

 Download Information

Expand FOA (Guidance) Attachment (Maximum 1)
Document Name Size Date Attached Description
MCHB HRSA-21-032 (U1E) Sickle Cell Disease Treatment Demonstration Program_ Final.pdf 416 kB 02/23/2021
Expand Application Package (Maximum 1)
No documents attached
Expand User Guide (Maximum 1)
No documents attached


Scroll to top